Special Research Program - SFB F47 Myeloproliferative Neoplasms

SFB F47 - Myeloproliferative Neoplasms

Myeloproliferative neoplasms (MPN) are the most frequent myeloid neoplasms, with an overall incidence of about 20-30 newly diagnosed patients per 100,000/year.

In this Special Research Program, funded by the Austrian Science Fund (FWF), six Institutes and more than 40 scientists worked together on the common goal to identify and characterize novel clinically relevant markers and targets, thereby providing novel strategies for improvement of diagnosis and therapy of patients suffering from myeloproliferative neoplasms.


Partner Institutes